in the news

The Path to Reemergence

Dino Muzzin, senior vice president of manufacturing operations at Emergent BioSolutions recently shared his insights with Pharma Manufacturing on lessons learned from COVID, and the path forward to future pandemic preparedness.

Read the full article here

 

CITATION

K. Langhauser, "Emergent BioSolutions: The path to reemergence," Pharma Manufacturing, February 10, 2022.

Utilizing Expertise & Experience for Successful Downstream Processing

Successful downstream processing provides isolation of the molecule of interest from extraneous constituents before formulation,...

READ MORE

Benefits of RABS and Isolator Technology in a Changing Regulatory Landscape

Mitigating risk is a key consideration for biopharmaceutical companies when planning their clinical trial material and/or drug...

READ MORE

Molecule to Market: Inside the Outsourcing Space

Emergent recently had the pleasure of participating in the Molecule to Market Podcast hosted by Ramen Sehgal from from ra...

READ MORE